LONDON BROKER RATINGS: Shore Capital raises WPP to Buy from Hold Read More
EXECUTIVE CHANGES: GSK adds scientific heft to board ahead of demerger Read More
TOP NEWS: GSK eyes steady annual payout after solid third quarter Read More
UK earnings, trading statements calendar - next 7 days Read More
LONDON BROKER RATINGS: UBS lifts Fresnillo; Jefferies says buy Drax Read More
PRESS: Private equity firms eye Glaxo's consumer unit - Bloomberg Read More
LONDON MARKET CLOSE: Stocks fall on weakening global growth outlook Read More
GlaxoSmithKline to base Consumer Healthcare arm in Weybridge, Surrey Read More
Novartis's Sandoz completes purchase of GSK's cephalosporin business Read More
LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight Read More
GSK's ViiV eyes another US green light for child HIV treatment Read More
UK dividends calendar - next 7 days Read More
TOP NEWS: GSK's ViiV posts positive three-year switch data for dovato Read More
GlaxoSmithKline's ViiV gets FDA priority review for HIV drug Read More
LONDON MARKET MIDDAY: Two votes cast to start BoE tapering Read More
LONDON MARKET OPEN: Royal Mail falls despite raising guidance Read More
PRESS: Activist Bluebell joins criticism of Glaxo CEO - Bloomberg Read More
LONDON BROKER RATINGS: Downgrades for miners Anglo American and BHP Read More
Victrex hires ex-BP executive Vivienne Cox to replace Pentz as chair Read More
GlaxoSmithKline's Nucala given positive opinion by EU's CHMP Read More
